Search Results

Filter
  • 1-10 of  60 results for ""FENOFIBRATE""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

[Fenofibrate 250 SR Pharmavit in patients with mixed hyperlipoproteinemia. Results of a study of 189 patients from 13 centers in the Czech Republic].

Subjects: Fenofibrate/Fenofibrate/Fenofibrate/*therapeutic use ; Hyperlipoproteinemias/Hyperlipoproteinemias/Hyperlipoproteinemias/*drug therapy ; Hypolipidemic Agents/Hypolipidemic Agents/Hypolipidemic Agents/*therapeutic use

  • Source: Casopis lekaru ceskych [Cas Lek Cesk] 2000 Jun 21; Vol. 139 (12), pp. 369-73.Publisher: Ceskoslovenska Lekarska Spolecnost Country of Publication: Czech Republic NLM ID: 0004743 Publication Model: Print

Record details

×
Editorial & Opinion

[On the article by Dr. R. Ceska, et al: Fenofibrat Pharmavit SR 250 in patients with mixed hyperlipoproteinemia].

Subjects: Fenofibrate/Fenofibrate/Fenofibrate/*therapeutic use ; Hyperlipoproteinemias/Hyperlipoproteinemias/Hyperlipoproteinemias/*drug therapy ; Hypolipidemic Agents/Hypolipidemic Agents/Hypolipidemic Agents/*therapeutic use

  • Source: Casopis lekaru ceskych [Cas Lek Cesk] 2001 Mar 29; Vol. 140 (6), pp. 188-9.Publisher: Ceskoslovenska Lekarska Spolecnost Country of Publication: Czech Republic NLM ID: 0004743 Publication Model: Print

Record details

×
Academic Journal

[The effect of treatment with fenofibrate on the risk profile of patients with metabolic syndrome and mixed dyslipidemia treated on an outpatient basis].

Subjects: Dyslipidemias/Dyslipidemias/Dyslipidemias/*drug therapy ; Fenofibrate/Fenofibrate/Fenofibrate/*therapeutic use ; Hypolipidemic Agents/Hypolipidemic Agents/Hypolipidemic Agents/*therapeutic use

  • Source: Vnitrni lekarstvi [Vnitr Lek] 2007 Apr; Vol. 53 (4), pp. 339-46.Publisher: Ambit Media Country of Publication: Czech Republic NLM ID: 0413602 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[Micronized fenofibrate and LDL-cholesterol subfractions].

  • Authors : Soska V; Fakultní nemocnice u svaté Anny v Brnĕ, Brno.

Subjects: Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*blood ; Cholesterol, LDL/Cholesterol, LDL/Cholesterol, LDL/*blood ; Fenofibrate/Fenofibrate/Fenofibrate/*therapeutic use

  • Source: Vnitrni lekarstvi [Vnitr Lek] 1999 Jul; Vol. 45 (7), pp. 441-3.Publisher: Ambit Media Country of Publication: Czech Republic NLM ID: 0413602 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia].

  • Authors : Ceska R; III. interní klinika 1. LF UK a VFN, Praha.; Sobra J

Subjects: Fenofibrate/Fenofibrate/Fenofibrate/*administration & dosage ; Fibrinogen/Fibrinogen/Fibrinogen/*analysis ; Hyperlipidemia, Familial Combined/Hyperlipidemia, Familial Combined/Hyperlipidemia, Familial Combined/*drug therapy

  • Source: Casopis lekaru ceskych [Cas Lek Cesk] 1996 Jul 26; Vol. 135 (13), pp. 413-6.Publisher: Ceskoslovenska Lekarska Spolecnost Country of Publication: Czech Republic NLM ID: 0004743 Publication Model: Print

Record details

×
Academic Journal

[Personal experience with 200mg of micronized fenofibrate (Lipanthyl 200 M) in the treatment of primary dyslipidemias].

Subjects: Fenofibrate/Fenofibrate/Fenofibrate/*administration & dosage ; Hyperlipidemias/Hyperlipidemias/Hyperlipidemias/*drug therapy ; Hypolipidemic Agents/Hypolipidemic Agents/Hypolipidemic Agents/*administration & dosage

  • Source: Vnitrni lekarstvi [Vnitr Lek] 1996 Apr; Vol. 42 (4), pp. 239-45.Publisher: Ambit Media Country of Publication: Czech Republic NLM ID: 0413602 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[The FIELD study presented and published. Unconvincing results of fenofibrates in diabetic patients].

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*complications ; Fenofibrate/Fenofibrate/Fenofibrate/*therapeutic use ; Hypolipidemic Agents/Hypolipidemic Agents/Hypolipidemic Agents/*therapeutic use

  • Source: Vnitrni lekarstvi [Vnitr Lek] 2006 Jan; Vol. 52 (1), pp. 80-4.Publisher: Ambit Media Country of Publication: Czech Republic NLM ID: 0413602 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[Effect of fibrates on VLDL and LDL lipoprotein composition and parameters of their oxidation in hypertriglyceridemia].

  • Authors : Zeman M; IV. interní klinika 1. LF UK a VFN, Praha. ; Zák A

Subjects: Fenofibrate/Fenofibrate/Fenofibrate/*therapeutic use ; Hypertriglyceridemia/Hypertriglyceridemia/Hypertriglyceridemia/*drug therapy ; Hypolipidemic Agents/Hypolipidemic Agents/Hypolipidemic Agents/*therapeutic use

  • Source: Casopis lekaru ceskych [Cas Lek Cesk] 2002 Apr 12; Vol. 141 (7), pp. 211-6.Publisher: Ceskoslovenska Lekarska Spolecnost Country of Publication: Czech Republic NLM ID: 0004743 Publication Model: Print

Record details

×
  • 1-10 of  60 results for ""FENOFIBRATE""